Briacell Competitors and Similar CompaniesClear all
Briacell's competitors and similar companies include Olema Oncology, Atossa Therapeutics, Myovant Sciences and HAVAH Therapeutics.
 Briacell Briacell is a clinical-stage biotech company that focuses on immuno-oncology and develops personalized immunotherapy for cancer. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  Atossa Therapeutics Atossa Therapeutics (formerly Atossa Genetics) is a pharmaceutical company focused on the development of breast cancer therapeutics. |  Myovant Sciences Myovant Sciences is a biopharmaceutical company that focuses on women’s health and prostate cancer. | ||
Founding Date | Founding Date 2004 | Founding Date 2007 | Founding Date 2009 | Founding Date 2016 | Founding Date 2005 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations West Vancouver, CA HQ Berkeley, US New York, US | Locations San Francisco, US HQ San Francisco, US | Locations Seattle, US HQ Seattle, US | Locations Brisbane, US HQ Basel, CH | Locations North Adelaide, AU HQ |
Employees | Employees 16 | Employees 9630% increase | Employees 667% decrease | Employees 1144% decrease | Employees 620% increase |
Valuation ($) | Valuation ($) 30.2 m | Valuation ($) 679.2 m | Valuation ($) 182.3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($26.6m) (FY, 2025) | Net income ($162.5m) (FY, 2025) | Net income ($34.8m) (FY, 2025) | Net income ($206m) (FY, 2022) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 145.1m | Total funding raised $ 7.6m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyAtossa Therapeutics
HQ
Seattle, US
Employees
6
Atossa Therapeutics (formerly Atossa Genetics) is a pharmaceutical company focused on the development of breast cancer therapeutics.
View companyMyovant Sciences
HQ
Brisbane, US
Myovant Sciences is a biopharmaceutical company that focuses on women’s health and prostate cancer.
View company
HAVAH Therapeutics
HQ
North Adelaide, AU
Employees
6↑ 20% increase
HAVAH Therapeutics is a women’s hormonal health biopharmaceutical company.
View company